AbCellera Biologics ABCL Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.32B	1.59B	1.59B	1.55B	1.54B	1.5B	1.54B	1.51B
Total Current Assets	929.8M	1.17B	1.14B	1.05B	1.03B	940.65M	930.74M	919.52M
Cash and Equivalents	476.14M	545.72M	790.62M	371.97M	386.54M	193.02M	179.75M	172.42M
Total Non-Current Assets	500.39M	539.96M	599.01M	707.34M	732.67M	790.45M	866.07M	869.88M
Total Liabilities	292.84M	384.78M	380.93M	302.24M	307.63M	289.42M	342.34M	329.42M
Total Current Liabilities	120.68M	213.42M	221.14M	106.05M	118.32M	89.59M	118.91M	110.24M
Total Non-Current Liabilities	172.16M	171.36M	159.79M	196.19M	189.31M	199.83M	223.43M	219.18M
Common Equity	757.79M	770.48M	782.83M	730.43M	734.37M	742.82M	744.76M	747.91M
Retained Earnings	267.67M	436.24M	429.45M	456.08M	426.19M	386.08M	355.55M	326.94M

Year End December 30 2023	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.01B	1.32B	1.54B	1.49B
Total Current Assets	813.33M	929.8M	1.03B	871.99M
Cash and Equivalents	594.12M	476.14M	386.54M	133.32M
Total Non-Current Assets	830.51M	1.03B	1.23B	1.15B
Total Liabilities	175.03M	292.84M	307.63M	335.78M
Total Current Liabilities	103.49M	120.68M	118.32M	119.01M
Total Non-Current Liabilities	73.74M	172.16M	189.31M	216.76M
Total Equity	830.51M	1.03B	1.23B	1.15B
Common Equity	716.31M	757.79M	734.37M	753.2M
Retained Earnings	114.2M	267.67M	426.19M	279.79M